KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Clorox (CLX) Long-Term Debt Repayments (2022)

Clorox has reported Long-Term Debt Repayments over the past 4 years, most recently at $1.1 billion for Q2 2022.

Quarterly results put Long-Term Debt Repayments at $1.1 billion for Q2 2022, changed N/A from a year ago — trailing twelve months through Jun 2023 was $1.1 billion (changed 0.0% YoY), and the annual figure for FY2022 was $1.4 billion, changed.
Long-Term Debt Repayments for Q2 2022 was $1.1 billion at Clorox, up from $500.0 million in the prior quarter.
Over the last five years, Long-Term Debt Repayments for CLX hit a ceiling of $1.1 billion in Q2 2022 and a floor of $1.1 billion in Q2 2022.